Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Exec Compensation
confidence 92%
filed 2026-08-26
Item 5.02
The disclosure centers on Amendment No. 1 to the Executive Employment Agreement with Jeffery Harris (CTO), which fixes the number of restricted stock units for the first-year annual bonus award at 49,778 units. This is a compensatory arrangement modification for a named executive officer, falling squarely within exec_compensation rather than exec_appointment or exec_departure, as the principal action is clarifying and fixing the equity grant terms of an existing employment agreement.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 85%
filed 2026-08-26
Item 5.02
Shareholders approved three compensatory arrangements: the 2026 Restricted Stock Units Plan, the 2026 Founder Share Subscription Warrants program, and the 2026 Stock Option Program, along with warrant delegation authority. These equity-based compensation plans were established for officers and employees.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-08-26
Item 5.02
The Board approved and granted fiscal year 2027 annual and long-term incentive plans to named executive officers, including cash incentive awards under the FY2027 AIP and equity awards (RSUs, SARs, and performance units) under the FY2027 LTIP. This is a direct disclosure of compensatory arrangements for executive officers, which is the core definition of exec_compensation under Item 5.02(e).
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 75%
filed 2026-08-26
Item 1.01
The filing discloses employment agreements with Brady Cobb (Interim CEO) and Michael Bondurant (Interim COO) that center on compensatory arrangements: base salaries ($300,000 and $275,000), performance-based cash bonuses tied to market capitalization milestones, option grants (231,250 and 200,000 respectively), and conditional RSU grants. While the agreements also formalize their executive appointments, the substantive disclosure focuses on the compensation structure and equity incentives, making this primarily a compensation event rather than a pure appointment.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-08-25
Item 5.02
The disclosure centers on compensatory arrangements for named executives and directors: establishment of incentive compensation plan performance goals and target payments for fiscal 2027, grant of RSU awards to Messrs. Larsen, Voorhees, and Hochberg (67,023, 36,192, and 33,512 RSUs respectively), and approval of long-term incentive plan performance measures and target cash awards for fiscal 2027-2029 (ranging from $150,000 to $400,000 for executives). This is a classic Item 5.02(e) disclosure of compensatory arrangements affecting named executives and directors.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 72%
filed 2026-08-25
Item 5.02
The disclosure centers on an Extension of Employment Agreement with Kevin S. Kim, the President and CEO, which amends the term and renewal provisions of his existing employment arrangement. While the extension itself does not describe new compensation or equity grants, it materially modifies the contractual terms governing his continued service and employment relationship through 2033, which constitutes a compensatory arrangement disclosure under Item 5.02(e). The extension of a CEO's employment term is material to investors assessing leadership continuity and executive compensation commitments.
View raw filing on EDGAR →
6-K
Exec Compensation
confidence 92%
filed 2026-08-25
EX-99.1
This exhibit is the CCH Holdings Ltd 2026 Second Equity Incentive Plan, a comprehensive equity compensation plan document that establishes the framework for granting stock options, restricted stock, restricted stock units, and other equity awards to directors, officers, employees, and consultants. The plan's stated purpose is to "attract and retain key personnel" and allow participants to "acquire and maintain an equity interest in the Company." This is a material disclosure of compensatory arrangements for executives and other eligible persons, falling squarely within the exec_compensation category.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 75%
filed 2026-08-25
Item 3.02
The filing discloses a material inducement stock option grant of 307,814 shares to an individual becoming an employee, approved by the Compensation Committee and issued under Nasdaq Rule 5635(c)(4). While Item 3.02 typically covers dilutive equity issuances, the substance here is an executive compensation arrangement—a stock option award with vesting conditions tied to continued service. This is a compensatory arrangement for a named executive or officer, making exec_compensation the most precise classification, though the Item 3.02 designation and unregistered securities language create some ambiguity.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-08-25
Item 5.02
The Board established FY 2027 performance measures and goals for the Enterprise Scorecard under the WPTIP and EAIP, approved LTIP performance measures for FY 2027–FY 2029, and modified existing incentive plan measures and goals across multiple performance cycles. These actions directly constitute compensatory arrangements for officers and executives, as they define the performance metrics and thresholds that determine incentive payouts under the company's executive compensation plans.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-08-25
The filing discloses adoption of the FY2027 Long Term Incentive Plan and FY2027 Short Term Incentive Plan, with specific equity and cash compensation awards to named executive officers (James Clark, James Galeese, Thomas Caneris) including RSUs, PSUs, and performance-based bonuses. Additionally, a $3,000,000 retention award of RSUs was granted to CEO James Clark, and his base salary was increased to $900,000 effective September 1, 2026. These are compensatory arrangements for directors and officers under Item 5.02(e).
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-08-25
Item 5.02
The disclosure describes the Compensation and Leadership Committee's approval of an Amended and Restated Executive Severance and Change in Control Policy effective August 19, 2026, covering the CEO Douglas Bland and other senior executives. This is a compensatory arrangement modification that materially affects severance and equity acceleration benefits for named executives, including base salary continuation periods (9–18 months), bonus multipliers (100–150% of target), and accelerated vesting provisions upon qualifying terminations and change-in-control events.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-08-25
Item 5.02
The filing discloses new employment agreements with two senior executives (CEO John H. Montgomery and Chief Banking Officer Bruce Sharp) containing material compensatory arrangements including base salaries ($495,000 and $294,500), annual bonus opportunities (20% for Montgomery), long-term equity incentive grants (20% of base salary for Montgomery), severance provisions (up to 3x base salary plus bonus upon change-in-control termination), and a new Split Dollar Life Insurance Agreement with Montgomery. These are compensatory arrangements of named executives that would materially affect investor assessment of executive costs and incentive structures.
View raw filing on EDGAR →
6-K
Exec Compensation
confidence 95%
filed 2026-08-24
EX-99
This exhibit is TAT Technologies' Compensation Policy for Executive Officers and Directors, adopted on September 8, 2026. It comprehensively addresses compensatory arrangements including base salary, benefits, cash bonuses, equity-based compensation, and change-of-control provisions. The policy establishes frameworks for determining and limiting executive compensation across multiple instruments and is subject to shareholder approval under Israeli Companies Law, making it a material governance disclosure of executive compensation arrangements.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-08-24
Item 5.02
The Compensation Committee revised CEO Joseph Visconti's base salary to $250,000 and established a $150,000 performance bonus contingent on successful closing of a merger with USFM Corporation. This is a direct disclosure of compensatory arrangements for a named executive officer under Item 5.02(e), making it an exec_compensation event. The material nature is reinforced by the merger-contingent bonus structure and the CEO's central role in the transaction.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-08-20
The filing discloses a new Executive Employment Agreement with CEO David Boulette dated August 17, 2026, replacing his prior agreement. The agreement specifies material compensatory arrangements including: base salary of $800,000 with automatic 10% annual increases, eligibility for annual bonuses, and up to 1,000,000 shares of Series A Convertible Preferred Stock (convertible into 150 million common shares) contingent on performance milestones. The filing also details severance provisions ($5,000,000 lump-sum payment upon termination without Cause or for Good Reason) and the Certificate of Designation for the Series A Preferred Stock with conversion, liquidation preference, and voting rights. This is a comprehensive compensatory arrangement disclosure under Item 5.02(e).
View raw filing on EDGAR →
6-K
Exec Compensation
confidence 92%
filed 2026-08-20
HSBC granted conditional awards to employees and former employees for 286,184 ordinary shares under the HSBC Share Plan 2011 on 19 August 2026. The announcement discloses compensatory arrangements including vesting schedules (3–5 years depending on employee category), retention periods, clawback provisions, and performance targets—all hallmarks of executive and employee equity compensation arrangements subject to Item 5.02(e) disclosure requirements.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-08-19
Item 5.02
The disclosure centers on new Executive Employment Agreements entered into on August 17, 2026 with Dr. Yuichi Iwaki (President and CEO) and Dr. Kazuko Matsuda (Chief Medical Officer). The filing details compensatory arrangements including base salaries ($690,246 for Dr. Iwaki; $540,143 for Dr. Matsuda), annual incentive bonuses (55% and 40% of base salary respectively), severance protection terms, equity acceleration provisions, and change-of-control benefits. These are material modifications to executive compensation and severance arrangements that would affect investor assessment of the company's obligations and executive retention.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-08-19
Item 5.02
The Compensation Committee approved and granted restricted stock awards to the CEO (James Rolke, 208,076 shares) and CFO (Chester S. Zygmont, III, 208,073 shares) effective August 17, 2026, pursuant to the 2021 Equity Incentive Plan. This is a direct disclosure of compensatory arrangements for named executives with specific vesting conditions tied to market capitalization milestones and time-based tranches, which is the core definition of exec_compensation under Item 5.02(e).
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-08-19
The filing discloses multiple compensatory arrangements for named executives and directors: (1) a stock option exchange effective July 24, 2026, converting 1,319,394 options to RSUs for Brian Carrico (199,188 RSUs), Adrian Miranda (199,106 RSUs), and Thomas Carrico (193,678 RSUs) with immediate vesting; (2) RSU grants on August 13, 2026, to four named executives (Carrico, Henrichs, Miranda, Carrico) vesting over three years; and (3) one-time equity awards of 127,120 shares to independent directors. These are material compensatory arrangements affecting executive and director compensation under the 2022 Plan.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-08-19
The filing discloses adoption of an amended and restated Employee Retention Plan and Retention Agreement on August 14, 2026, establishing compensatory arrangements for eligible employees including retention incentives tied to Change in Control events and salary increases during Insolvency periods. This is a material disclosure of executive and employee compensation arrangements under Item 5.02(e), distinct from a departure or appointment.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 72%
filed 2026-08-19
Item 1.01
The company entered into a consulting agreement providing equity compensation of 100,000 shares total (50,000 immediately and 50,000 conditional on continued service through 2027) vesting over two years for strategic advisory services on AI technology.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-08-19
Item 5.02
The Compensation Committee approved compensatory arrangements for two named executives: a $200,000 base salary increase and $10 million in special equity awards (RSUs and PSUs) for CEO Paul Keel, and a $1.5 million performance-based equity award for CFO Eric Hammes.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-08-19
Item 5.02
On August 17, 2026, the Compensation Committee approved a special grant of 880,000 performance-based, price-vesting restricted stock units to Matthew Bromberg, the Company's President and CEO, as a one-time supplemental performance award contingent on continued service and substantial stock price appreciation.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-08-17
Item 5.02
Stockholders approved an amendment and restatement of the Company's 2005 Equity Compensation Plan to increase available shares by 2,500,000, a material modification to the equity plan affecting future executive and employee compensation capacity.
View raw filing on EDGAR →
6-K
Exec Compensation
confidence 85%
filed 2026-08-17
EX-99.1
Zhibao Technology Inc. disclosed a form executive employment agreement establishing material compensatory arrangements for an executive officer, including cash compensation, equity incentives, benefits, and severance/termination provisions.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-08-17
Item 5.02
Fabrinet adopted a fiscal 2027 Cash Bonus Plan for named executive officers, approved base salary increases ranging 6.7% to 11.1%, and granted equity awards of RSUs, PSUs, and Stretch PSUs totaling $30 million across four executives with specified performance metrics and vesting schedules.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-08-14
Item 5.02
The disclosure centers on a new participation agreement under the Supplemental Executive Retirement Plan with Gerald J. Ritzert, the CFO, providing eight annual credits totaling $300,000 and specifying retirement age and payment terms. This is a compensatory arrangement for a named executive officer, fitting the definition of exec_compensation under Item 5.02(e).
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 85%
filed 2026-08-14
Item 5.02
The disclosure centers on the termination of the Rhinebeck Bank Executive Long-Term Incentive and Retention Plan on May 19, 2026, and the resulting full vesting of account balances for named executive officers Jamie Bloom and Kevin Nihill. This is a material modification to compensatory arrangements for officers, triggering full acceleration of deferred compensation benefits. While the filing is under Item 5.02, the principal event is the plan termination and its compensatory consequences, not a departure or appointment.
View raw filing on EDGAR →
6-K
Exec Compensation
confidence 92%
filed 2026-08-14
EX-99.1
The exhibit announces the grant of incentive stock options (1,499,543 shares at $2.37 exercise price), restricted share units (782,680 RSUs), and deferred share units (128,454 DSUs) to officers, directors, and employees under the Company's rolling equity plans. This is a compensatory arrangement disclosure typical of Item 5.02(e) in domestic 8-Ks, disclosing equity grants to named executives and directors with specified vesting schedules and terms.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-08-14
Item 5.02
The disclosure centers on a Restricted Stock Transfer Agreement between Mithaq Capital (controlling shareholder) and Muhammad Asif Seemab (Vice Chairman, President, and Interim CEO) for 500,000 restricted shares with performance-based vesting tied to market capitalization milestones and continued employment. This is a compensatory arrangement for a named executive officer, fitting the exec_compensation category despite the technical structure as a transfer from the controlling shareholder rather than a direct company grant.
View raw filing on EDGAR →
6-K
Exec Compensation
confidence 92%
filed 2026-08-14
EX-99.1
The press release announces a grant of 68,000 stock options to officers, employees, and consultants under the Company's Long-Term Incentive Plan, with an exercise price of $1.87 and a five-year term vesting in three equal annual installments. This is a compensatory arrangement for named executives and employees, fitting the definition of exec_compensation. The disclosure is material as equity grants to management affect shareholder interests and capital structure.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-08-14
Item 5.02
The disclosure centers on an equity grant of 20,000 RSUs to Kannan Sugantharaman, the Chief Financial and Operations Officer, with a three-year vesting schedule. This is a compensatory arrangement for a named executive officer, fitting the definition of exec_compensation. While Item 5.02 covers multiple event types, the principal action disclosed is the award of equity compensation, not a departure or appointment.
View raw filing on EDGAR →
6-K
Exec Compensation
confidence 95%
filed 2026-08-14
The 6-K discloses approval of remuneration arrangements for the CEO (Mr. Lee Seng Chi), another director (Mr. Thien Chiet Chai), and three independent directors, effective June 11, 2026. The arrangements specify monthly cash and share-based compensation amounts, with share-based compensation to be settled through issuance of Class B ordinary shares. This is a classic executive compensation disclosure under Item 5.02(e) equivalent, material because it establishes new compensatory arrangements for named executives and involves equity issuance.
View raw filing on EDGAR →
6-K
Exec Compensation
confidence 85%
filed 2026-08-14
On August 11, 2026, the Board approved an increase of 2,500,000 ordinary shares reserved for issuance under the Company's 2024 Employee Equity Incentive Plan, raising the total from 112,667 to 2,612,667 shares. This is a material amendment to the equity compensation plan that expands the pool available for employee grants and would affect investor assessment of dilution and executive/employee compensation arrangements.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-08-14
Item 5.02
The disclosure centers on an amendment to CFO Frank DeMaria's Employment Agreement that modifies his severance entitlement to one times Annual Base Compensation upon termination without Just Cause. This is a compensatory arrangement modification affecting a named executive officer's severance terms, which is the hallmark of exec_compensation under Item 5.02(e). While the amendment is relatively modest in scope, severance modifications to C-suite officers are material to investors assessing executive cost structures and retention incentives.
View raw filing on EDGAR →
6-K
Exec Compensation
confidence 92%
filed 2026-08-12
The 6-K discloses a grant of 15,060 warrants to employees on August 11, 2026, with an exercise price of $254.57 per share and a four-year vesting schedule (25% at one year, then 1/36th monthly). This is a compensatory arrangement for named executives and employees under the company's Articles of Association, materially affecting equity incentive arrangements and shareholder dilution.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-08-12
Item 5.02
This disclosure describes a Board-approved repricing of underwater stock options held by named executive officers and other employees, reducing exercise prices from a range of $13.99–$24.59 per Share to $4.14 per Share. The repricing affects approximately 1.7 million shares and includes retention requirements designed to incentivize continued service. This is a compensatory arrangement modification under Item 5.02(e), distinct from an executive departure or appointment, and materially affects the value of equity compensation for the CEO, CMO, and CFO.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-08-12
Item 5.02
The Compensation Committee approved a special, one-time performance-based stock option award to CEO Garo H. Armen consisting of 1,971,500 options with a 10-year term and complex vesting tied to stock price milestones (3x to 8x the $7.78 exercise price). This is a compensatory arrangement for a named executive officer disclosed under Item 5.02(e), distinct from an appointment or departure.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-08-12
Item 5.02
The disclosure centers on the Compensation Committee's approval of a stock option grant to Randy Gilbert, the CEO/CFO, under the 2021 Stock Incentive Plan. The grant of 100,000 shares at $4.51 per share with a four-year vesting schedule is a compensatory arrangement for a named executive officer, fitting the exec_compensation category. This is material as equity grants to senior executives affect investor assessment of compensation practices and dilution.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-08-12
Item 5.02
Stockholders approved the Amended and Restated 2021 Incentive Plan, which increases available shares from 1.2 million to 2.45 million for equity awards to directors, officers, and employees.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-08-11
Item 5.02
The Company disclosed material compensatory arrangements for named executives in connection with the restructuring: CEO Matt McLaughlin's base salary reduced 20% and STIP forfeited for 2026; CFO Mary Margaret Curry's base salary reduced 10%, STIP reduced 50%, plus new equity grants (60,000 options and 60,000 RSUs); and Chief Commercial Officer Steve Bagdasarian's transition agreement with severance modifications.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-08-11
Item 5.02
TransAct Technologies entered into a severance agreement with Troy W. Ingianni, CFO, Treasurer and Secretary, specifying detailed compensatory arrangements including termination severance payments, change-in-control severance with accelerated vesting of equity awards, and restrictive covenants.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-08-10
Item 5.02
The Company amended contractual severance benefits for named executive officers and other employees, including enhanced severance in connection with the Change in Control (the Merger), and approved a $3.5 million transaction bonus program for executives.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 75%
filed 2026-08-10
Item 5.02
In connection with the Merger Agreement, equity awards (Company Options, RSUs, and PSUs) held by four Named Executives (Sanyal, Maheshwari, Hartmann, and Jonaitis) will be accelerated and vested, with aggregate cash payouts totaling approximately $14.4 million.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-08-10
Item 5.02
The filing discloses approval by the Compensation and Talent Development Committee of a new executive short-term incentive bonus plan effective October 1, 2026, which supersedes and replaces multiple prior bonus plans. This is a compensatory arrangement for directors and officers (all Section 16 executive officers are designated as Participants), involving material changes to incentive structure and bonus eligibility criteria. The disclosure is characteristic of Item 5.02(e) executive compensation disclosures.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-08-10
Item 5.02
The disclosure centers on an amendment to Dr. Christoph Glingener's employment agreement as CTO, detailing modifications to his compensatory arrangements including base salary affirmation (€400,000), annual incentive cash bonus targets (60% of base), time-based RSU grants (75% of base, capped at €903,729), and three-year performance stock unit awards (€903,729 target, capped at €2,000,000). The Amendment also establishes a total annual remuneration cap of €2,800,000. This is a classic executive compensation disclosure under Item 5.02(e), distinct from a departure or appointment.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-08-10
Item 5.02
The disclosure centers on a compensatory arrangement for Richard L. Sowers, the President and CEO, specifically the grant of a stock option for 30,000 shares under the 2026 Omnibus Equity Incentive Plan with an exercise price of $85.65 and performance-based vesting tied to 2028 audited financial statements. This is a classic executive compensation event under Item 5.02(e), distinct from an appointment or departure.
View raw filing on EDGAR →
6-K
Exec Compensation
confidence 95%
filed 2026-08-10
The 6-K discloses a grant of 1,000,000 ordinary shares on August 4, 2026, pursuant to the Company's 2026 Omnibus Equity Plan to officers and employees, including 200,000 shares to CEO Yi Shao and 200,000 shares to CFO Lijuan Ding. This is a direct disclosure of equity compensation arrangements for named executives, which falls squarely within the exec_compensation category. The grants vested immediately and were formalized through Unrestricted Stock Award Agreements.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-08-07
Item 5.02
The Compensation Committee amended severance agreements for four named executives (M. Paul Bunn, James "Tripp" Grant, Dustin Koehl, and Joey Ballard) to add new retirement and voluntary separation benefits, including 6 months of salary continuation and 6 months of COBRA reimbursement upon 18 months' notice. This is a material modification of compensatory arrangements for officers, fitting the exec_compensation category under Item 5.02(e).
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-08-07
Item 5.02
The disclosure centers on a First Amendment to the Employment Agreement with Tracy W. Krohn (CEO, President, and Chairman) that modifies his annual base salary to a minimum of $1,000,000 with an annual review provision and a no-decrease clause. This is a compensatory arrangement modification for a named executive officer, fitting the exec_compensation category. The materiality is high given Krohn's senior role and the explicit salary floor and protection against reduction.
View raw filing on EDGAR →